Drug Shortage Report for SANDOZ ALFUZOSIN

Last updated on 2025-01-14 History
Report ID 237728
Drug Identification Number 02304678
Brand name SANDOZ ALFUZOSIN
Common or Proper name ALFUZOSIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ALFUZOSIN HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100PRT
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-09-16
Estimated end date 2025-01-10
Actual end date 2025-01-13
Shortage status Resolved
Updated date 2025-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-01-14 English Compare
v12 2025-01-13 French Compare
v11 2025-01-13 English Compare
v10 2024-12-02 French Compare
v9 2024-12-02 English Compare
v8 2024-10-07 French Compare
v7 2024-10-07 English Compare
v6 2024-09-30 French Compare
v5 2024-09-30 English Compare
v4 2024-09-17 English Compare
v3 2024-09-16 French Compare
v2 2024-09-16 English Compare
v1 2024-09-16 English Compare

Showing 1 to 13 of 13